Intraoperative Neuromonitoring (IONM) Market Report by Product and Services (Systems, Accessories, Services), Source Type (Insourced Monitoring, Outsourced Monitoring), Application (Spinal Surgery, Neurosurgery, Vascular Surgery, ENT Surgery, Orthopedic Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers (ASCs)), and Region 2024-2032
The global intraoperative neuromonitoring (IONM)market size reached US$ 3.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.2 Billion by 2032, exhibiting a growth rate (CAGR) of 6.2% during 2024-2032.
Market Size in 2023
US$ 3.5 Billion
Market Forecast in 2032
US$ 6.2 Billion
Market Growth Rate 2024-2032
An intraoperative neuromonitoring (IONM) system comprises a group of procedures that can detect, monitor, and confirm nerve function and help minimize the odds of neurological problems during or after neurological surgical procedures. It reduces the risks of nerve function being damaged as a result of improper positioning of the patient or any neurophysiologically-relevant nerve structures. An IONM allows surgeons to identify electrophysiologic changes during spine, head or neck surgery, which may be crucial in extending incisions, placing implants, positioning limbs, and performing retraction techniques that can prevent permanent nerve damage. Using targeted neurostimulation, nerve structures can be identified to prevent potential damage, thus allowing surgeons to focus on optimizing interventions while preserving function. Consequently, these systems are extensively used in neuro, ENT, emergency, visceral, cardiothoracic, orthopedic, and vascular surgeries.
The market is majorly driven by the augmenting focus on patient safety during complex surgical procedures. This can be attributed to a considerable rise in the prevalence of chronic neurovascular disorders, such as epilepsy, stroke, Parkinson’s disease and Alzheimer’s disease. In addition to this, the escalating demand for minimally invasive and non-invasive surgeries resulting in a higher uptake of advanced intraoperative neuromonitoring devices is propelling the market. Moreover, the growing trend of medical tourism across the globe is also creating lucrative growth opportunities for the market. The market is further driven by the expanding expenditure on advanced healthcare services. Some of the other factors providing an impetus to the market include the paradigm shift towards outsourced monitoring, the increasing geriatric population that is susceptible to developing neurological disorders, favorable government initiatives and reimbursement plans, and extensive research and development (R&D), collaborations, and joint ventures among the key players.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global intraoperative neuromonitoring (IONM)market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product and services, source type, application and end user.
Breakup by Product and Services:
Breakup by Source Type:
Breakup by Application:
Breakup by End User:
Ambulatory Surgical Centers (ASCs)
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accurate Monitoring LLC, Computational Diagnostics Inc., inomed Medizintechnik GmbH, Intranerve LLC, Medtronic plc, Natus Medical Incorporated, NeuroMonitoring Technologies Inc., Neurophysiology Services Asia, Nihon Kohden Corporation, NuVasive Inc., Specialtycare Inc. and Technomed.
Base Year of the Analysis
Product and Services, Source Type, Application, End User, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Accurate Monitoring LLC, Computational Diagnostics Inc., inomed Medizintechnik GmbH, Intranerve LLC, Medtronic plc, Natus Medical Incorporated, NeuroMonitoring Technologies Inc., Neurophysiology Services Asia, Nihon Kohden Corporation, NuVasive Inc., Specialtycare Inc. and Technomed
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global Intraoperative Neuromonitoring (IONM) market was valued at US$ 3.5 Billion in 2023.
We expect the global Intraoperative Neuromonitoring (IONM) market to exhibit a CAGR of 6.2% during 2024-2032.
The growing need for patient safety during complex surgical procedures, along with the rising prevalence of chronic neurovascular disorders, such as epilepsy, stroke, Parkinson’s disease, etc., is primarily driving the global Intraoperative Neuromonitoring (IONM) market.
The sudden outbreak of the COVID-19 pandemic had led to the postponement of elective cardiothoracic, orthopedic, and vascular surgeries to reduce the risk of the coronavirus infection upon hospital visits and interaction with medical equipment, thereby negatively impacting the global market for Intraoperative Neuromonitoring (IONM).
Based on the source type, the global Intraoperative Neuromonitoring (IONM) market has been divided into insourced monitoring and outsourced monitoring. Currently, insourced monitoring exhibits a clear dominance in the market.
Based on the application, the global Intraoperative Neuromonitoring (IONM) market can be categorized into spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and others. Among these, neurosurgery holds the largest market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global Intraoperative Neuromonitoring (IONM) market include Accurate Monitoring LLC, Computational Diagnostics Inc., inomed Medizintechnik GmbH, Intranerve LLC, Medtronic plc, Natus Medical Incorporated, NeuroMonitoring Technologies Inc., Neurophysiology Services Asia, Nihon Kohden Corporation, NuVasive Inc., Specialtycare Inc., and Technomed.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.